Evaluation of the antitumor activity of moronecidin (Piscidin)-like peptide in combination with anti-PD-1 antibody against melanoma tumor

Document Type : Original Article


1 The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran

2 Autoimmune Diseases Research Center, Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran

3 Department of Biochemistry and Hematology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan Iran

4 Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran


Objective(s): Immunotherapy has changed the landscape of oncology over the last decade and has become a standard of care for various cancers. Researchers previously demonstrated that B16-F10 melanoma in C57Bl6 mice is resistant to immune checkpoint inhibitors. The goal of this study was to investigate how anti-PD1 antibodies functioned in combination with a new antimicrobial peptide (AMP) called moronecidin-like peptide (MLP).
Materials and Methods: We studied the cytotoxic effect of AMP on the B10-F16 tumor cell line with the MTT experiment. The necrotic and apoptotic cells were determined by Presidium iodide (PI) /Annexin V staining and flow cytometry-based methods. Mice were inoculated subcutaneously with B10-F16 tumor cells in the mammary gland. Each group was sacrificed two weeks after the last injection to examine tumor-specific CD8+ T cell responses using flow cytometry. 
Results: Annexin V and PI staining assay revealed that MPL significantly induces apoptosis in B16F10 cells. It should be noted that MLP in combination with anti-PD-1 improved antigen-specific T-cell responses synergistically (P=0.01) when compared with respective monotherapy. Furthermore, when compared with the respective monotherapies, combination therapy significantly controlled tumor growth in B10-F16 tumor cells and increased survival rate.
Conclusion: Treatments with anti-PD-1 inhibitors alone had only a minor effect on tumor size, whereas combination therapy resulted in significant tumor growth control and increased animal survival. MLP therapy combined with anti-PD-1 antibody improves anti-tumor immune response in addition to inducing tumor cell apoptosis. As a result, the evidence suggests that intratumoral injection of MPL can improve anti-PD-1 antibody antitumor response.


Main Subjects

1. Schadendorf D, van Akkooi AC, Berking C, Griewank KG, Gutzmer R, Hauschild A, et al. Melanoma. Lancet 2018;392:971-984.
2. Ahmed B, Qadir MI, Ghafoor S. Malignant melanoma: Skin 
cancer− diagnosis, prevention, and treatment. Crit Rev Eukaryo Gene Expr 2020;30: 291-297.
3. Wang Y, Deng W, Li N, Neri S, Sharma A, Jiang W, et al. Combining immunotherapy and radiotherapy for cancer treatment: Current challenges and future directions. Front Pharmacol 2018;9:1-11.
4. Mohseninia A, Dehghani P, Bargahi A, Rad-Malekshahi M, Rahimikian R, Movahed A, et al. Harnessing self-assembling peptide nanofibers to prime robust tumor-specific CD8 T cell responses in mice. Int Immunopharmacol 2022;104:1-13.
5.    Mohammadi M, Dehghani P, Mohseninia A, Roozbehani M, Hemphill A, Hesamizadeh K. Incorporation of the tat cell‐penetrating peptide into nanofibers improves the respective antitumor immune response. J Cell Physiol 2021;236:1401-1417.
6. He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res 2020;30:660-669.
7. Wang TW, Johmura Y, Suzuki N, Omori S, Migita T, Yamaguchi K, et al. Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes. Nature 2022;611:358-364.
8.    Kamphorst AO, Wieland A, Nasti T, Yang S, Zhang R, Barber DL, et al. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science 2017;355:1423-1427.
9.    Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science 2018;359:1350-1355.
10.    Findlay EG, Currie AJ, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology 2019;8:1608106.
11.    Tornesello AL, Borrelli A, Buonaguro L, Buonaguro FM, Tornesello ML. Antimicrobial peptides as anticancer agents: Functional properties and biological activities. Molecules 2020;25:1-25.
12.    Zhong C, Zhang L, Yu L, Huang J, Huang S, Yao Y. A review for antimicrobial peptides with anticancer properties: re-purposing of potential anticancer agents. BIO Integration 2021;1:156-167.
13.    Taheri B, Mohammadi M, Nabipour I, Momenzadeh N, Roozbehani M. Identification of novel antimicrobial peptide from Asian sea bass (Lates calcarifer) by in silico and activity characterization. PLoS One 2018;13:e0206578.
14.    Cheng M-H, Pan C-Y, Chen N-F, Yang S-N, Hsieh S, Wen Z-H, et al. Piscidin-1 induces apoptosis via mitochondrial reactive oxygen species-regulated mitochondrial dysfunction in human osteosarcoma cells. Sci Rep 2020;10:1-15.
15.    Mohammadi M, Taheri B, Momenzadeh N, Salarinia R, Nabipour I, Farshadzadeh Z, et al. Identification and characterization of novel antimicrobial peptide from hippocampus comes by in silico and experimental studies. Mar Biotechnol 2018;20:718-728.
16.    Raju SV, Sarkar P, Kumar P, Arockiaraj J. Piscidin, fish antimicrobial peptide: Structure, classification, properties, mechanism, gene regulation and therapeutical importance. Int J Pept Res Ther 2021;27:91-107.
17.    Leite ML, da Cunha NB, Costa FF. Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment. Pharmacol Ther 2018;183:160-176.
18.    Ghasemi A, Ghavimi R, Momenzadeh N, Hajian S, Mohammadi M. Characterization of antitumor activity of a synthetic moronecidin-like peptide computationally predicted from the tiger tail seahorse hippocampus comes in tumor-bearing mice. Int J Pept Res Ther 2021;27:2391-2401. 
19.    Gómez-Cuadrado L, Tracey N, Ma R, Qian B, Brunton VG. Mouse models of metastasis: progress and prospects. Dis Model Mech 2017;10:1061-1074.
20.    Ju X, Fan D, Kong L, Yang Q, Zhu Y, Zhang S, et al. Antimicrobial peptide Brevinin-1RL1 from frog skin secretion induces apoptosis and necrosis of tumor cells. Molecules 2021;26:1-15.
21.    Kuo H-M, Tseng C-C, Chen N-F, Tai M-H, Hung H-C, Feng C-W, et al. MSP-4, an antimicrobial peptide, induces apoptosis via activation of extrinsic Fas/FasL-and intrinsic mitochondria-mediated pathways in one osteosarcoma cell line. Mar Drugs 2018;16:8-27.
22.    Tsai T-L, Li A-C, Chen Y-C, Liao Y-S, Lin T-H. Antimicrobial peptide m2163 or m2386 identified from Lactobacillus casei ATCC 334 can trigger apoptosis in the human colorectal cancer cell line SW480. Tumor Biolo 2015;36:3775-3789.
23.    Jia J, Zheng Y, Wang W, Shao Y, Li Z, Wang Q, et al. Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells. Mol Med Rep 2017;15:240-248.
24.    Papo N, Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 2005;62:784-790.
25.    Huang Y-B, He L-Y, Jiang H-Y, Chen Y-X. Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Int J Mol Sci 2012;13:6849-6862.
26.    Irazazabal LN, Porto WF, Ribeiro SM, Casale S, Humblot V, Ladram A, et al. Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan. Biochim Biophys Acta 2016;1858:2699-2708.
27.    Taheri B, Mohammadi M, Momenzadeh N, Farshadzadeh Z, Roozbehani M, Dehghani P, et al. Substitution of lysine for isoleucine at the center of the nonpolar face of the antimicrobial peptide, piscidin-1, leads to an increase in the rapidity of bactericidal activity and a reduction in toxicity. Infect Drug Resist 2019;12:1629-1647.
28.    Kumar P, Kizhakkedathu JN, Straus SK. Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules. 2018;8:4-28.
29.    Su B-C, Liu Y-C, Ting C-H, Lyu P-C, Chen J-Y. Antimicrobial peptide TP4 targets mitochondrial adenine nucleotide translocator 2. Mar drugs 2020;18:417-429.
30.     Li C, Liu H, Yang Y, Xu X, Lv T, Zhang H, et al. N-myristoylation of antimicrobial peptide CM4 enhances its anticancer activity by interacting with cell membrane and targeting mitochondria in breast cancer cells. Front Pharmacol 2018;9:1-15. 
31.    Deslouches B, Di YP. Antimicrobial peptides with selective antitumor mechanisms: Prospect for anticancer applications. Oncotarget 2017;8:46635-46651.
32.    Yang C, Xia B-R, Zhang Z-C, Zhang Y-J, Lou G, Jin W-L. Immunotherapy for ovarian cancer: Adjuvant, combination, and neoadjuvant. Front Immunol 2020;11:1-18. 
33.    Rubinchik E, Dugourd D, Algara T, Pasetka C, Friedland HD. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models. Int J Antimicrob Agents 2009;34:457-461.
34.    Ghavimi R, Mohammadi E, Akbari V, Shafiee F, Jahanian-Najafabadi A. In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells. Res Pharm Sci 2020;15:200-208.
35.    Hancock RE, Haney EF, Gill EE. The immunology of host defence peptides: Beyond antimicrobial activity. Nat Rev Immunol 2016;16:321-334.
36.    Hilchie A, Hoskin D, Power Coombs M. Anticancer activities of natural and synthetic peptides. Adv Exp Med Biol 2019; 1117:131-147.
37.    Pahar B, Madonna S, Das A, Albanesi C, Girolomoni G. Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections. Vaccines 2020;8:517.
38.    Lee EY, Lee MW, Wong GC, editors. Modulation of toll-like receptor signaling by antimicrobial peptides. Semin Cell Dev Biol 2019; 88:173-184.
39.    Guryanova SV, Ovchinnikova TV. Immunomodulatory and allergenic properties of antimicrobial peptides. Int J Mol Sci 2022;23:1-25. 
40.    Saxena M, Balan S, Roudko V, Bhardwaj N. Towards superior dendritic-cell vaccines for cancer therapy. Nat Biomed Eng 2018;2:341-346.
41.    Lee J, Lee DG. Antimicrobial peptides (AMPs) with dual mechanisms: Membrane disruption and apoptosis. J Microbiol Biotechnol 2015;25:759-764.
42.    Woznicki JA, Flood P, Bustamante-Garrido M, Stamou P, Moloney G, Fanning A, et al. Human BCL-G regulates secretion of inflammatory chemokines but is dispensable for induction of apoptosis by IFN-γ and TNF-α in intestinal epithelial cells. Cell Death Dis 2020;11:1-15.
43.    Park SJ, Kim JM, Kim J, Hur J, Park S, Kim K, et al. Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns. Proc Natl Acad Sci 2018;115:E11721-E11730.
44.    Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 2014;515:568-571.